Structured medication review for polypharmacy – systematic review
Jeindl R, Kern-Kim J
Record ID 32018015450
English
Authors' objectives:
Polypharmacy (≥5 long-term medicines) is common among older, multimorbid adults and increases medication-related risks. Structured medication reviews (SMRs) aim to improve medication safety. This report synthesised evidence on effectiveness, safety, organisation and costs, and compared European implementation to inform decision-making in Austria.
Authors' results and conclusions:
Two umbrella reviews and three systematic reviews were included, showing low risk of bias but predominantly low-quality primary evidence. SMRs reduced potentially inappropriate medication and missing indicated therapies, with small effects on adherence. No clear mortality reduction was found; results for hospitalisations and quality of life were mixed, with no relevant safety concerns.
Authors' recommendations:
SMRs should primarily be considered a measure to enhance medication safety. Implementation should prioritise high-risk patients, standardised components, clear communication pathways, use of digital medication data, and accompanying health services research.
Authors' methods:
Systematic searches for umbrella reviews, systematic reviews and guidelines published since 2020. Outcomes included medication-related, clinical, organisational and economic endpoints; quality was assessed using ROBIS and AGREE II. A qualitative analysis compared implementation models in six European countries.
Details
Project Status:
Completed
Year Published:
2026
URL for published report:
https://eprints.aihta.at/1600/1/HTA-Projektbericht_Nr.175.pdf
URL for additional information:
https://eprints.aihta.at/1600
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Austria
MeSH Terms
- Polypharmacy
- Medication Review
- Drug-Related Side Effects and Adverse Reactions
- Overtreatment
- Deprescriptions
Keywords
- Structured medication review
- polypharmacy
- medication safety
- deprescribing
- implementation
Contact
Organisation Name:
Austrian Institute for Health Technology Assessment
Contact Address:
Josefstaedter Strasse 39, A-1080 Vienna, Austria
Contact Name:
office@aihta.at
Contact Email:
office@aihta.at
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.